keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Leucomethylene blue mesylate (TRx0237 mesylate) 是一种 Methylene blue (亚甲基蓝)的还原形式, 亚甲基蓝是一种化学指示剂和生物染色剂。它是一种具有口服活性的二代 tau 蛋白聚集的抑制剂 (Ki=为0.12 μM),可用于阿尔兹海默症的研究。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
10 mg | ¥ 647 | 现货 | ||
50 mg | ¥ 1,927 | 现货 | ||
200 mg | ¥ 3,880 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 529 | 现货 |
产品描述 | Leucomethylene blue mesylate (TRx0237 mesylate) is a second-generation tau protein aggregation inhibitor for the treatment of Alzheimer's disease (AD) and frontotemporal dementia. |
靶点活性 | Tau:0.12 μM (Ki) |
体外活性 | TRx 0237 (LMTX?) is a second-generation tau protein aggregation inhibitor for the treatment of Alzheimer's disease (AD) and frontotemporal dementia. It is a purified forms of Methylene Blue, an old drug that predates the FDA and is being widely used in Africa for the treatment for malaria as well as for methemoglobinemia and other conditions[2]. An in vitro study showed the ability of TRx 0237 in disrupting PHFs(paired helical filaments) isolated from Alzheimer's Disease brain tissues at the concentration at 0.16 μM[1]. |
体内活性 | TRx 0237 dose-dependently rescues the learning impairment and restores behavioral flexibility in a spatial problem-solving water-maze task in L1 (minimum effective dose: 9 mg MT/kg for TRx0237) and correctes motor learning in L66 (effective doses: 4 mg MT/kg). It reduces the number of tau-reactive neurons, particularly in the hippocampus and entorhinal cortex in L1 and in a more widespread manner in L66[1]. |
别名 | N3,N3,N7,N7-四甲基-10H-吩噻嗪-3,7-二胺二甲磺酸盐, TRx0237 mesylate, TRx0237 (LMTX) mesylate, Methylene blue leuco base mesylate salt, Leucomethylene Blue Dimesylate |
分子量 | 477.62 |
分子式 | C16H19N3S·2CH4O3S |
CAS No. | 1236208-20-0 |
keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: 87 mg/mL (182.2 mM)
DMSO: 88 mg/mL (184.2 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 2.0937 mL | 10.4686 mL | 20.9371 mL | 52.3429 mL |
5 mM | 0.4187 mL | 2.0937 mL | 4.1874 mL | 10.4686 mL | |
10 mM | 0.2094 mL | 1.0469 mL | 2.0937 mL | 5.2343 mL | |
20 mM | 0.1047 mL | 0.5234 mL | 1.0469 mL | 2.6171 mL | |
50 mM | 0.0419 mL | 0.2094 mL | 0.4187 mL | 1.0469 mL | |
100 mM | 0.0209 mL | 0.1047 mL | 0.2094 mL | 0.5234 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Leucomethylene blue mesylate 1236208-20-0 Cytoskeletal Signaling Neuroscience Beta Amyloid Microtubule Associated TRx-0237 Methylene blue leuco base Aβ25-35 aggregation Tau Methylene blue leuco base Mesylate Inhibitor N3,N3,N7,N7-四甲基-10H-吩噻嗪-3,7-二胺二甲磺酸盐 TRx0237 mesylate Leucomethylene blue Mesylate inhibit TRx0237 (LMTX) Mesylate β-amyloid peptide Amyloid-β Disease Leucomethylene Blue Leucomethylene blue TRx0237 TRx0237 (LMTX) mesylate TRx0237 Mesylate TRx 0237 Methylene blue leuco base mesylate salt Alzheimer's Leucomethylene Blue Dimesylate Abeta inhibitor